Análisis Argos
ACA
ACACara
Arcosa, Inc. · Industrials
US$ 145.28
precio al 2026-07-28
Valor justo Argos*
US$ 112
vs. su valor justo
−23%
Score Argos
45/100
LA RESPUESTA
El mercado le pide crezca 60% al año — más de lo que ha demostrado (8.2%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
Las ganancias crecieron 122% el último año.
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
!Balance frágil: la deuda pesa sobre el negocio.
VALOR1/6FUTURO3/6PASADO3/6SALUD2/6DIVIDENDO1/6
El Iris de calidad
VALOR1/6FUTURO3/6PASADO3/6SALUD2/6DIVIDENDO1/6
ValorCotiza por encima de su valor justo
FuturoCrecimiento moderado
PasadoHistorial aceptable
SaludBalance razonable
DividendoEl dividendo aún duerme
Score Argos45de 100Cara
Ingresos12%
US$ 2.9 B
Margen operativo53%
11.8%
Flujo de caja libre42%
US$ 0.2 B
Deuda neta
US$ 1.3 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 7.1B
P/E34.2x
EV/EBITDA15x
FCF yield2.5%
ROIC7.5%
Margen operativo11.8%
Crecim. ingresos+12.2%/año
Piotroski F8/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

businesswire.com · 23 jul
Arcosa, Inc. to Announce Second Quarter 2026 Results on August 5, 2026
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, will announce its results for the second quarter ended June 30, 2026 after markets close on Wednesday, August 5, 2026.As previously announced on June 22, 2026, the Company has entered into a merger agreement with CRH for CRH to acquire 100% of Arcosa in an all-cash transaction for $150 per share, subject to Arcosa stockholders' and regulatory approvals. Due.
zacks.com · 23 jul
Has Arcosa (ACA) Outpaced Other Construction Stocks This Year?
Here is how Arcosa (ACA) and Emcor Group (EME) have performed compared to their sector so far this year.
zacks.com · 21 jul
Do Options Traders Know Something About Arcosa Stock We Don't?
Investors need to pay close attention to ACA stock based on the movements in the options market lately.
globenewswire.com · 6 jul
Halper Sadeh LLC is Investigating Whether ACA, TECH, IRDM, LCII are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation.
globenewswire.com · 6 jul
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LCI Industries (NYSE – LCII), Iridium Communications Inc. (Nasdaq – IRDM), Bio-Techne Corporation (Nasdaq – TECH), Arcosa, Inc. (NYSE – ACA)
BALA CYNWYD, Pa., July 06, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
globenewswire.com · 2 jul
Shareholder Alert: Ademi LLP investigates whether Arcosa, Inc. is obtaining a Fair Price for Public Shareholders
MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Arcosa (NYSE: ACA) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with CRH.
globenewswire.com · 30 jun
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LCI Industries (NYSE – LCII), Iridium Communications Inc. (Nasdaq – IRDM), Bio-Techne Corporation (Nasdaq – TECH), Arcosa, Inc. (NYSE – ACA)
BALA CYNWYD, Pa., June 30, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
gurufocus.com · 24 jun
Arcosa Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcosa, Inc. - ACA
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swick and Foti[/url], LLC (“KSF”) are investigating the propos

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.